According to Fortune Business Insights, the global small animal imaging market size was valued at USD 1.31 billion in 2025. The market is projected to grow from USD 1.42 billion in 2026 to USD 2.59 billion by 2034, exhibiting a CAGR of 7.84% during the forecast period of 2026–2034.
Market Overview
The global small animal imaging market is expanding as pharmaceutical companies, biotechnology organizations, academic institutions, and veterinary hospitals increasingly adopt advanced imaging technologies. These systems help researchers understand disease mechanisms, evaluate experimental treatments, and improve the efficiency of preclinical studies.
Small animal imaging is particularly important in oncology research, drug monitoring, cancer cell detection, and epigenetics. It allows researchers to observe biological changes over time and assess treatment responses in animal models.
The market includes imaging equipment and associated reagents and consumables. Increasing technological advancements, improvements in image resolution, and the development of integrated imaging platforms are strengthening the industry's growth prospects.
For detailed market insights: https://www.fortunebusinessinsights.com/small-animal-imaging-market-111720
Market Trends
The small animal imaging market is witnessing several technological developments that are improving research accuracy, imaging efficiency, and diagnostic capabilities.
Growing Adoption of Multimodal Imaging Systems
The increasing adoption of multimodal imaging systems is a major trend in the industry. These platforms combine optical, nuclear, MRI, and ultrasound technologies to provide complementary anatomical, molecular, and functional information. This integration helps researchers improve study accuracy and obtain comprehensive biological insights.
Multimodal imaging can also reduce the number of animals required for experiments by enabling researchers to collect multiple types of information within integrated workflows.
Integration of Artificial Intelligence in Image Analysis
Artificial intelligence (AI) and advanced software analytics are increasingly being integrated into imaging workflows. These technologies help automate image processing, quantify biomarkers, and improve research reproducibility. AI-powered solutions also support faster interpretation of complex imaging data and enhance the efficiency of preclinical studies.
Development of Compact and High-Resolution Equipment
Manufacturers are focusing on miniaturized imaging equipment with improved resolution and faster image acquisition. These developments allow researchers to visualize smaller biological structures more precisely. Non-ionizing imaging technologies are also gaining attention because of their potential to reduce radiation exposure and support animal welfare.
Market Drivers
Rising Preclinical Research and Drug Development Activities
The expansion of preclinical research and pharmaceutical drug development is a major factor driving market growth. Pharmaceutical and biotechnology companies use small animal imaging to evaluate drug effectiveness, monitor disease progression, and study therapeutic responses.
These technologies enable real-time, non-invasive observation of biological processes in animal models. They also help researchers identify ineffective drug candidates during early development stages, improving research efficiency and supporting better investment decisions.
Expansion of Veterinary Diagnostic Imaging
The growing availability of advanced veterinary diagnostic services is creating new opportunities for the market. Increasing pet healthcare expenditure and demand for sophisticated diagnostic procedures are encouraging veterinary hospitals and clinics to adopt advanced imaging technologies.
Imaging systems support disease identification, surgical planning, and treatment monitoring. The availability of compact and cost-effective systems is also helping expand imaging capabilities beyond specialized veterinary referral centers.
Increasing Focus on Animal Welfare
Researchers are increasingly prioritizing non-invasive imaging methods that reduce stress and minimize the need for repeated invasive procedures. Advanced imaging technologies allow longitudinal monitoring of disease progression and treatment effectiveness, supporting research objectives while addressing animal welfare considerations.
Market Segmentation
The small animal imaging market is segmented by product, application, and end user.
By Product
- Equipment: This segment dominates the market with approximately 70% market share. It includes optical imaging systems, nuclear imaging systems, MRI systems, and ultrasound systems. Growing demand for high-resolution imaging and multimodal platforms supports segment growth.
- Reagents and Consumables: This segment accounts for approximately 30% of the market. It includes contrast agents, radiotracers, fluorescent probes, and imaging kits used in research and diagnostic procedures.
By Application
- Drug Monitoring: Accounting for approximately 35% of the market, this segment leads due to increasing use of imaging to evaluate pharmacokinetics, drug distribution, and therapeutic effectiveness.
- Cancer Cell Detection: This segment represents nearly 30% of the market. Optical and nuclear imaging technologies support tumor identification, cancer progression monitoring, and evaluation of treatment responses.
- Epigenetics: Representing approximately 20% of the market, this segment benefits from increasing research into gene regulation, molecular expression, and biological pathways.
- Others: This category accounts for around 15% and includes cardiovascular, metabolic, and infectious disease research.
By End User
- Veterinary Hospitals: This segment holds approximately 45% of the market, supported by increasing investments in advanced diagnostic equipment, specialized veterinary care, and treatment monitoring.
- Veterinary Clinics: Accounting for around 35%, this segment benefits from the growing availability of compact and cost-effective imaging technologies.
- Others: Representing approximately 20%, this category includes academic institutions, contract research organizations, and government research laboratories.
Key Players
The global small animal imaging market includes established medical technology manufacturers and specialized preclinical imaging companies. Major players identified by Fortune Business Insights include:
- PerkinElmer
- Bruker
- FUJIFILM Corporation
- Mediso Ltd.
- MILabs B.V.
- MR Solutions
- Aspect Imaging Ltd.
- TriFoil Imaging
PerkinElmer holds approximately 18% of the market, while Bruker accounts for around 15%. These companies focus on improving imaging performance, expanding product portfolios, and developing advanced solutions for biomedical research and veterinary applications.
Regional Analysis
The global small animal imaging market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America
North America dominates the global small animal imaging market, accounting for approximately 38% of the market share. The region benefits from a strong pharmaceutical industry, established biotechnology companies, advanced academic research institutions, and well-developed veterinary healthcare infrastructure.
The U.S. is a major contributor due to its extensive preclinical research activities and investments in biomedical innovation. Increasing adoption of multimodal imaging systems and AI-integrated analytical platforms is further supporting regional growth.
Europe
Europe accounts for approximately 27% of the global market. The region benefits from established academic research networks, expanding veterinary healthcare infrastructure, and investments in life sciences. Germany holds approximately 9% of the global market, while the U.K. accounts for around 8%. Growing emphasis on precision imaging, animal welfare, and non-invasive research technologies is supporting adoption.
Asia Pacific
Asia Pacific represents approximately 25% of the global market. Increasing investments in biotechnology, pharmaceutical research, and veterinary healthcare are driving regional expansion. China accounts for approximately 10% of the global market, while Japan represents around 7%. Growing research infrastructure and collaborations with international imaging manufacturers are creating additional opportunities.
Rest of the World
The Rest of the World accounts for approximately 10% of the global market. Increasing investments in healthcare infrastructure, veterinary services, and biomedical research are supporting gradual adoption. However, limited access to advanced imaging equipment and high implementation costs remain challenges in several emerging markets.
Competitive Landscape
The competitive landscape is characterized by technological innovation, product development, and strategic collaborations. Leading companies are focusing on developing advanced imaging systems with improved resolution, faster acquisition speeds, and enhanced analytical capabilities.
PerkinElmer and Bruker are prominent market participants, accounting for approximately 18% and 15% of the market, respectively. Other companies, including FUJIFILM Corporation, Mediso, MILabs, and MR Solutions, are strengthening their product portfolios through technological developments.
Manufacturers are also introducing compact MRI systems, hybrid imaging platforms, and AI-powered image analysis software. These developments are helping research organizations improve experimental accuracy, reduce operational complexity, and enhance research outcomes.
Future Outlook
The small animal imaging market is expected to experience steady growth through 2034, supported by increasing preclinical research activities, pharmaceutical development, and expanding veterinary diagnostic services.
The integration of artificial intelligence, multimodal imaging, and advanced software analytics is expected to improve image interpretation and research efficiency. Furthermore, increasing demand for non-invasive diagnostic techniques will encourage manufacturers to develop innovative imaging platforms that support animal welfare.
Emerging markets are also expected to offer growth opportunities as investments in biotechnology, pharmaceutical research, and veterinary healthcare infrastructure increase.
However, high equipment acquisition costs, specialized infrastructure requirements, and the need for trained professionals may restrict adoption among smaller research institutions and veterinary clinics. Addressing these challenges will be important for expanding the industry's global reach.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/small-animal-imaging-market-111720
Conclusion
The global small animal imaging market is gaining importance in biomedical research, pharmaceutical development, and veterinary diagnostics. Increasing demand for preclinical imaging, technological advancements, and growing investments in animal healthcare are supporting industry expansion.
Equipment remains the leading product segment, while drug monitoring represents the largest application segment. North America continues to dominate the market, supported by its advanced research infrastructure and strong pharmaceutical industry. Despite challenges related to equipment costs and regulatory requirements, innovations in AI-powered analytics and multimodal imaging are expected to create significant growth opportunities through 2034.
Frequently Asked Questions (FAQs)
1. What is the global small animal imaging market size?
According to Fortune Business Insights, the global small animal imaging market was valued at USD 1.31 billion in 2025 and is projected to reach USD 2.59 billion by 2034.
2. What is the expected CAGR of the small animal imaging market?
The market is expected to grow at a CAGR of 7.84% during the forecast period of 2026–2034.
3. Which is the leading product segment in the small animal imaging market?
Equipment is the leading product segment, accounting for approximately 70% of the global market share.
4. Which application dominates the small animal imaging market?
Drug monitoring dominates the application segment, accounting for approximately 35% of the market share.
5. Who are the major players in the small animal imaging market?
Major players include PerkinElmer, Bruker, FUJIFILM Corp
Uncover Japan’s Market Trends Explore the Latest Small Animal Imaging Market Insights
Comments